Nav1.5
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) | |
---|---|
Identifiers | |
Symbol | SCN5A |
Alt. symbols | LQT3, CMD1E, Nav1.5 |
Entrez | 6331 |
HUGO | 10593 |
OMIM | 600163 |
RefSeq | NM_198056 |
UniProt | Q14524 |
Other data | |
Locus | Chr. 3 p21 |
WikiDoc Resources for Nav1.5 |
Articles |
---|
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Nav1.5 at Clinical Trials.gov Clinical Trials on Nav1.5 at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Nav1.5
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Nav1.5 Risk calculators and risk factors for Nav1.5
|
Healthcare Provider Resources |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
The Nav1.5 sodium ion channel protein is encoded by the SCN5A gene. Mutations in the gene are associated with long QT syndrome type 3 (LQT3), Brugada syndrome, and idiopathic ventricular fibrillation.